Medicare should cover new drug for Alzheimer’s

As a past caregiver for three relatives that had Alzheimer’s disease, access to treatments that can change the course of the disease in a meaningful way for people living with early Alzheimer’s is of critical importance to me.

The Food and Drug Administration approved lecanemab. Based on results from very strong clinical trials, leading Alzheimer’s researchers agree this treatment changes the course of the disease in a meaningful way for people with early Alzheimer’s. Because of the decision the Centers for Medicaid & Medicare Services (CMS) has put in place, Medicare will not cover this treatment. Never before has CMS imposed such drastic access barriers, especially for people facing a fatal disease. This is the first time that Medicare will not cover an FDA-approved treatment upon approval. Every FDA-approved drug is covered by Medicare, except for Alzheimer’s.

CMS’s policy is unjustified, harmful and unfair. Just as is true for individuals with every other disease, people living with Alzheimer’s and their doctors should be able to decide if an FDA-approved treatment is right for them and should have it covered. People living with Alzheimer’s deserve better, and need support from Congress. The Alzheimer’s Association has filed a formal request asking CMS to provide full, unrestricted coverage for FDA-approved Alzheimer’s treatments.

Please join me in urging U.S. Rep. Rick Larsen to demand CMS ensure individuals living with Alzheimer’s have equitable access to FDA-approved Alzheimer’s treatments.

Go to to learn more.

Bruce Holroyd


Talk to us

More in Opinion

Editorial cartoons for Saturday, May 27

A sketchy look at the news of the day.… Continue reading

File - A teenager holds her phone as she sits for a portrait near her home in Illinois, on Friday, March 24, 2023. The U.S. Surgeon General is warning there is not enough evidence to show that social media is safe for young people — and is calling on tech companies, parents and caregivers to take "immediate action to protect kids now." (AP Photo Erin Hooley, File)
Editorial: Warning label on social media not enough for kids

The U.S. surgeon general has outlined tasks for parents, officials and social media companies.

Comment: Hospice care isn’t giving up; it’s a gift of time, love

End-of-life care offers patients and families comfort, better quality of life and time to say goodbye.

Comment: State, local libraries rebuilding lives after prison

For those leaving prison, a library card is key to starting again. A new program offers that key.

Comment: Veterans struggling with addiction need our support

Connect veterans with the services they need through encouragement, understanding and advocacy.

Forum: Imagine our losses without Endangered Species Act

Marking its 50th year, the act has saved numerous species of animals and plants and their habitats.

Forum: Especially at time of peace, U.S. must honor its fallen

As diplomacy takes precedence over military action, Memorial Day reminds us of our duty to history.

Editorial cartoons for Friday, May 26

A sketchy look at the news of the day.… Continue reading

Anabelle Parsons, then 6, looks up to the sky with binoculars to watch the Vaux's swifts fly in during Swift's Night Out, Sept. 8, 2018 in Monroe. (Olivia Vanni / The Herald)
Editorial: Birders struggle with legacy, name of Audubon

Like other chapters, Pilchuck Audubon is weighing how to address the slaveholder’s legacy.

Most Read